Makiko Ueda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Makiko Ueda has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Hiroko Fukushima
Department of Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
1 shared publicationHiroyuki Itabe
Department of Biological Chemistry, School of Pharmceutical Sciences, Showa University, Tokyo, Japan
1 shared publicationHisato Jomura
Department of Internal Medicine, Wakakoukai Hospital, Osaka, Japan
1 shared publicationMasahiko Ohsawa
Department of Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
1 shared publicationNorifumi Kawada
Department of Hepatology, Osaka City University Graduate School of Medicine, Osaka, Japan
1 shared publicationShoichi Ehara
Department of Internal Medicine and Cardiology, Osaka City University Graduate School of Medicine, Osaka, Japan
1 shared publication
Latest Publications
- Open Access
- 22 February 2006
- Published by Wolters Kluwer Health in Hepatology
- Vol. 43 (3) , 506-514
Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: Impact on disease progression
Nonalcoholic steatohepatitis/nonalcoholic fatty liver disease is considered to be a hepatic manifestation of various metabolic disorders. However, its precise pathogenic mechanism is obscure. Oxidative stress and consequent lipid peroxidation seem to play a pivotal role in disease progression. In this study, we analyzed the localization of oxidized phosphatidylcholine (oxPC), a lipid peroxide that serves as a ligand for scavenger receptors, in livers of patients with this steatotic disorder. Specimens of non-alcoholic fatty liver disease (15 autopsy livers with simple steatosis and 32 biopsy livers with steatohepatitis) were examined via immunohistochemistry and immunoelectron microscopy using a specific antibody against oxPC. In addition, scavenger receptor expression, hepatocyte apoptosis, iron deposition, and inflammatory cell infiltration in the diseased livers were also assessed. Oxidized phosphatidylcholine was mainly localized to steatotic hepatocytes and some macrophages/Kupffer cells. A few degenerative or apoptotic hepatocytes were also positive for oxPC. Immunoelectron microscopy showed oxPC localized to cytoplasmic/intracytoplasmic membranes including lipid droplets. Steatotic livers showed enhanced expression of scavenger receptors. The number of oxPC cells was correlated with disease severity and the number of myeloperoxidase-positive neutrophils, but not with the degree of iron deposition. In conclusion , distinct localization of oxPC in liver tissues suggest that neutrophil myeloperoxidase-derived oxidative stress may be crucial in the formation of oxPC and the progression of steatotic liver disease. (Hepatology 2006;43:506–514.)
- 22 February 2006
- Published by Wolters Kluwer Health in Hepatology
- Vol. 43 (3) , 506-514
Open AccessLocalization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: Impact on disease progression
Nonalcoholic steatohepatitis/nonalcoholic fatty liver disease is considered to be a hepatic manifestation of various metabolic disorders. However, its precise pathogenic mechanism is obscure. Oxidative stress and consequent lipid peroxidation seem to play a pivotal role in disease progression. In this study, we analyzed the localization of oxidized phosphatidylcholine (oxPC), a lipid peroxide that serves as a ligand for scavenger receptors, in livers of patients with this steatotic disorder. Specimens of non-alcoholic fatty liver disease (15 autopsy livers with simple steatosis and 32 biopsy livers with steatohepatitis) were examined via immunohistochemistry and immunoelectron microscopy using a specific antibody against oxPC. In addition, scavenger receptor expression, hepatocyte apoptosis, iron deposition, and inflammatory cell infiltration in the diseased livers were also assessed. Oxidized phosphatidylcholine was mainly localized to steatotic hepatocytes and some macrophages/Kupffer cells. A few degenerative or apoptotic hepatocytes were also positive for oxPC. Immunoelectron microscopy showed oxPC localized to cytoplasmic/intracytoplasmic membranes including lipid droplets. Steatotic livers showed enhanced expression of scavenger receptors. The number of oxPC cells was correlated with disease severity and the number of myeloperoxidase-positive neutrophils, but not with the degree of iron deposition. In conclusion , distinct localization of oxPC in liver tissues suggest that neutrophil myeloperoxidase-derived oxidative stress may be crucial in the formation of oxPC and the progression of steatotic liver disease. (Hepatology 2006;43:506–514.)